Design, Synthesis, and Biological Evaluation of 3-(Imidazo[1,2-a]pyrazin-3-ylethynyl)-4-isopropyl-N-(3-((4-methylpiperazin-1-yl)methyl)-5-(trifluoromethyl)phenyl)benzamide as a Dual Inhibitor of Discoidin Domain Receptors 1 and 2

Discoidin-domain receptors 1 and 2 (DDR1 and DDR2) are new potential targets for anti-inflammatory-drug discovery. A series of heterocycloalkynylbenzimides were designed and optimized to coinhibit DDR1 and DDR2. One of the most promising compounds, 5n, tightly bound to DDR1 and DDR2 proteins with Kd values of 7.9 and 8.0 nM; potently inhibited the kinases with IC50 values of 9.4 and 20.4 nM, respectively; and was significantly less potent for a panel of 403 wild-type kinases at 1.0 μM. DDR1- and DDR2-kinase inhibition by 5n was validated by Western-blotting analysis in primary human lung fibroblasts. The compound also dose-dependently inhibited lipopolysaccharide (LPS)-induced interleukin 6 (IL-6) release in vitro and exhibited promising in vivo anti-inflammatory effects in an LPS-induced-acute-lung-injury (ALI) mouse model. Compound 5n may serve as a lead compound for new anti-inflammatory drug discovery.

[1]  A. Bullock,et al.  Tetrahydroisoquinoline-7-carboxamide Derivatives as New Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors. , 2017, ACS medicinal chemistry letters.

[2]  Yong Xu,et al.  Structure-Based Design of Tetrahydroisoquinoline-7-carboxamides as Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors , 2016, Journal of medicinal chemistry.

[3]  Xiaokun Li,et al.  Discovery of a New Inhibitor of Myeloid Differentiation 2 from Cinnamamide Derivatives with Anti-Inflammatory Activity in Sepsis and Acute Lung Injury. , 2016, Journal of medicinal chemistry.

[4]  M. Meyerson,et al.  Characterization of DDR2 Inhibitors for the Treatment of DDR2 Mutated Nonsmall Cell Lung Cancer , 2015, ACS chemical biology.

[5]  Christopher W Murray,et al.  Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors. , 2015, ACS medicinal chemistry letters.

[6]  Mei-Rong Du,et al.  Discoidin domain receptors (DDRs): potential implications in atherosclerosis. , 2015, European journal of pharmacology.

[7]  Edward W. Lowe,et al.  Discoidin domain receptor 1 (DDR1) kinase as target for structure-based drug discovery. , 2015, Drug discovery today.

[8]  Xiaoyun Lu,et al.  Small molecule discoidin domain receptor kinase inhibitors and potential medical applications. , 2015, Journal of medicinal chemistry.

[9]  H. Nguyen,et al.  Identification of type II and III DDR2 inhibitors. , 2014, Journal of medicinal chemistry.

[10]  Paul H. Huang,et al.  Discoidin domain receptors: a proteomic portrait , 2014, Cellular and Molecular Life Sciences.

[11]  A. Pozzi,et al.  Discoidin domain receptors in disease. , 2014, Matrix biology : journal of the International Society for Matrix Biology.

[12]  H. Chapman,et al.  Activated alveolar epithelial cells initiate fibrosis through secretion of mesenchymal proteins. , 2013, The American journal of pathology.

[13]  Philip R. Evans,et al.  How good are my data and what is the resolution? , 2013, Acta crystallographica. Section D, Biological crystallography.

[14]  U. Bhawal,et al.  Tropomyosin receptor kinases B and C are tumor progressive and metastatic marker in colorectal carcinoma. , 2013, Human pathology.

[15]  Young‐Mi Lee,et al.  Induction of IL-12 production by the activation of discoidin domain receptor 2 via NF-κB and JNK pathway. , 2013, Biochemical and biophysical research communications.

[16]  Ke Ding,et al.  Discovery and optimization of 3-(2-(Pyrazolo[1,5-a]pyrimidin-6-yl)ethynyl)benzamides as novel selective and orally bioavailable discoidin domain receptor 1 (DDR1) inhibitors. , 2013, Journal of medicinal chemistry.

[17]  Xiangxing Ma,et al.  RNA Interference against Discoidin Domain Receptor 2 Ameliorates Alcoholic Liver Disease in Rats , 2013, PloS one.

[18]  Xiaoyun Lu,et al.  Design, synthesis, and biological evaluation of 3-(1H-1,2,3-triazol-1-yl)benzamide derivatives as Potent Pan Bcr-Abl inhibitors including the threonine(315)→isoleucine(315) mutant. , 2012, Journal of medicinal chemistry.

[19]  Young‐Mi Lee,et al.  Collagen I enhances functional activities of human monocyte-derived dendritic cells via discoidin domain receptor 2. , 2012, Cellular immunology.

[20]  Ke Ding,et al.  Design, synthesis, and biological evaluation of novel conformationally constrained inhibitors targeting epidermal growth factor receptor threonine⁷⁹⁰ → methionine⁷⁹⁰ mutant. , 2012, Journal of medicinal chemistry.

[21]  R. Fridman,et al.  Discoidin domain receptor tyrosine kinases: new players in cancer progression , 2012, Cancer and Metastasis Reviews.

[22]  G. Jarai,et al.  Collagen I Induces Discoidin Domain Receptor (DDR) 1 Expression through DDR2 and a JAK2-ERK1/2-mediated Mechanism in Primary Human Lung Fibroblasts* , 2011, The Journal of Biological Chemistry.

[23]  Vincent B. Chen,et al.  MolProbity: all-atom structure validation for macromolecular crystallography , 2009, Acta crystallographica. Section D, Biological crystallography.

[24]  J. Hao,et al.  LOK is a major ERM kinase in resting lymphocytes and regulates cytoskeletal rearrangement through ERM phosphorylation , 2009, Proceedings of the National Academy of Sciences.

[25]  E. Buchdunger,et al.  Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib. , 2008, European journal of pharmacology.

[26]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[27]  W. Vogel,et al.  Discoidin domain receptor 1 null mice are protected against hypertension-induced renal disease. , 2006, Journal of the American Society of Nephrology : JASN.

[28]  W. Vogel,et al.  Discoidin domain receptor 1-deficient mice are resistant to bleomycin-induced lung fibrosis. , 2006, American journal of respiratory and critical care medicine.

[29]  L. Wodicka,et al.  A small molecule–kinase interaction map for clinical kinase inhibitors , 2005, Nature Biotechnology.

[30]  Zukang Feng,et al.  Automated and accurate deposition of structures solved by X-ray diffraction to the Protein Data Bank. , 2004, Acta crystallographica. Section D, Biological crystallography.

[31]  W. Farrar,et al.  Activation of Discoidin Domain Receptor 1 Isoform b with Collagen Up-Regulates Chemokine Production in Human Macrophages: Role of p38 Mitogen-Activated Protein Kinase and NF-κB , 2004, The Journal of Immunology.

[32]  K. Sonogashira,et al.  Development of Pd–Cu catalyzed cross-coupling of terminal acetylenes with sp2-carbon halides , 2002 .

[33]  S. Friedman,et al.  DDR2 receptor promotes MMP-2-mediated proliferation and invasion by hepatic stellate cells. , 2001, The Journal of clinical investigation.

[34]  B. Leitinger.  Discoidin domain receptor functions in physiological and pathological conditions. , 2014, International review of cell and molecular biology.

[35]  Andrew G. W. Leslie,et al.  Processing diffraction data with mosflm , 2007 .

[36]  Vincent B. Chen,et al.  Acta Crystallographica Section D Biological , 2001 .

[37]  Hsin C. Lin,et al.  DDR 2 receptor promotes MMP-2 – mediated proliferation and invasion by hepatic stellate cells , 2001 .

[38]  K. Vaddi.  MIP-1α – Macrophage inflammatory protein-1α , 1997 .